Spectrum Pharmaceuticals, Inc.
KITS AND METHODS FOR TREATING CANCERS

Last updated:

Abstract:

A kit containing a crystalline form of a quinazoline compound. More particularly, the crystalline form is derived from the compound of 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)pi- peridin-1-yl)prop-2-en-1-one. Also disclosed is a method of treating cancers with the crystalline form or a kit thereof.

Status:
Application
Type:

Utility

Filling date:

12 Sep 2019

Issue date:

10 Feb 2022